Your session is about to expire
← Back to Search
Procedure
SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus) for Obstructive Sleep Apnea
N/A
Waitlist Available
Led By Erikka Washington, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of procedure
Awards & highlights
Study Summary
This trial will compare the effects of two different methods of oxygenation and ventilation on obese patients during colonoscopy.
Eligible Conditions
- Obstructive Sleep Apnea, Obesity
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ prior to endoscopic intubation,during the procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to endoscopic intubation,during the procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time taken from initiation of induction to the first airway intervention
Secondary outcome measures
Amount of propofol administered during induction
Anesthesiologist satisfaction score as assessed by the visual analog scale (VAS)
Change in alertness of subject as assessed by the Modified Observer's Assessment of Alertness/Sedation Scale (MOAAS)
+13 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group B: SuperNO2VA™EtCO2Experimental Treatment1 Intervention
Group II: Group A: Standard care with a facemask.Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus)
2022
N/A
~140
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,838 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
9 Previous Clinical Trials
885 Total Patients Enrolled
Erikka Washington, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- If you need to have an unplanned surgery or medical procedure during the study.You have had an allergic reaction to propofol in the past.You are currently experiencing a worsening of congestive heart failure.You have a sudden worsening of respiratory conditions like COPD or asthma.You have a surgically-created opening in your windpipe called a tracheostomy.You are currently having a medical procedure called a colonoscopy.You are ASA physical status I, II, or III.You have a tumor located in the upper part of your voice box or just below it.You are not eligible to use the SuperNoVa software.You have a high body mass index (BMI) of 35 or above, or have been diagnosed with or suspected to have obstructive sleep apnea.You have untreated heart disease caused by reduced blood flow.You are pregnant.You have a blockage or slow movement in your digestive system.
Research Study Groups:
This trial has the following groups:- Group 1: Group A: Standard care with a facemask.
- Group 2: Group B: SuperNO2VA™EtCO2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies still available for participants in this experiment?
"This trial does not currently appear to be recruiting new participants, as the last edit was made on November 7th 2022. Despite this, clinicaltrials.gov lists 290 other trials that are actively looking for patients at this time."
Answered by AI
Who else is applying?
What state do they live in?
Texas
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
Share this study with friends
Copy Link
Messenger